Gino Santini
Independent Non-Executive ChairmanMr. Gino Santini, M.B.A., is Independent Non-Executive Chairman of Lakefront Biotherapeutics NV (formerly known as Galapagos NV) from April 28, 2026. He is Independent Chairman of Collegium Pharmaceutical, Inc. from May 15, 2025 and has been an Independent Director since July 24, 2012 and also served as its Lead Independent Director since May 2015 until May 15, 2025. Mr. Santini joined the Collegium Pharmaceutical, Inc. on July 24, 2012. He serves as Independent Chairman of the Board of COMPASS Pathways plc since September 03, 2024 and serves as its Lead Director. He served as Independent Director of Enalare Therapeutics Inc. since November 2020 until 2025. Mr. Santini serves as a Director of Artax BioPharma Inc. Mr. Santini had been an Independent Director of Intercept Pharmaceuticals, Inc. since November 24, 2015 until 2023 and had been Lead Independent Director since February 2018 until 2023. Mr. Santini had been a Director of Allena Pharmaceuticals, Inc. since February 14, 2012 until September 2, 2022 and had been its Lead Director since February 1, 2019 until September 2, 2022. Mr. Santini served as Senior Vice President of Corporate Strategy & Business Development at Eli Lilly and Company from June 2007 until retirement in December 2010. Mr. Santini served as the President of U.S. Operations at Eli Lilly and Company from 1999 to 2004. He served as Senior Vice President of Corporate Strategy and Policy at Eli Lilly and Company from August 2004 to 2007. He served as the President of the U.S.A. from 1999 to 2004. Mr. Santini joined Lilly & Co. in 1983 as a Financial Planning Associate in Italy and held various positions in the financial and marketing components in Italy and Indianapolis. He served as the Pharmaceutical Director for Lilly affiliate at Eli Lilly and Company in Belgium Since 1990 and he served as General Manager of Eli Lilly in Mexico City since 1991. He served as Area Director of Latin America of Eli Lilly and Company from 1994 to 1995 and as its Vice President of Corporate Strategy and Business Development since 1995 with the responsibility for the public policy and development group added in early 1996. He served as the President of the women's health business unit at Eli Lilly from 1997 to 1999. Mr. Santini retired after many year career at Eli Lilly and Company. He had been Independent Chairman of AMAG Pharmaceuticals, Inc. since April 16, 2014 until November 16, 2020 and served as its Independent Director since February 2012 until November 16, 2020. He serves as Chairman of Noble of Indiana. He had been an Independent Director of Horizon Therapeutics Public Limited Company (formerly known as Horizon Pharma plc) since March 8, 2012 until October 06, 2023; and ImClone Systems LLC since November 21, 2008. He is an Independent Director of Inspiration Biopharmaceuticals, Inc. since September 18, 2012. He has been a Director at Intarcia Therapeutics, Inc. since July 26, 2013. He serves as an Associate Member Board of the National Association of Chain Drug Stores. He served as a Director of Vitae Pharmaceuticals, Inc. from September 3, 2014 to October 25, 2016. He serves as a Director of Italian financial holding company. He served as an Independent Director at Sorin SpA since April 30, 2012 to 2015. Since December 2010, Mr. Santini has been a senior advisor providing financing and business consulting services to venture capital, pharmaceutical and biotechnology companies. He served as Chairman of the National Pharmaceutical Council and of Noble of Indiana. He served as Director for United Way. He was named the 2009 Campaign Chairman at United Way of Central Indiana. Mr. Santini was graduated with B.S degree in Mechanical Engineering from the University of Bologna, Italy in 1981 and a Master of Business Administration from the Simon School of Business, University of Rochester in 1983.
Positions
- Company NameLakefront Biotherapeutics NVStock CodeLKFTPositionIndependent Non-Executive ChairmanColleagues
- HOHenry O. GosebruchCEO & Executive Director
- GSGino SantiniIndependent Non-Executive Chairman
- ALAaron L. CoxChief Financial Officer
- CCChristina CarlsonChief Operating Officer
- GSGlenn SchulmanHead of Investor Relations
- FWFred W. BlakesleeExecutive VP & General Counsel
- JVJane Veronica GriffithsNon-Executive Independent Director
- DADawn A. SvoronosNon-Executive Independent Director
- NGNeil G. JohnstonNon-Executive Independent Director
- Company NameCOMPASS Pathways plcStock CodeCMPSPositionIndependent ChairmanColleagues
- KKKabir Kumar NathCEO & Executive Director
- GSGino SantiniIndependent Chairman
- TLTeri LoxamChief Financial Officer
- GGGuy GoodwinChief Medical Officer
- SDStephen D. SchultzSenior Vice President of Investor Relations
- KBKelley BoucherChief People Officer
- DKDaphne KarydasIndependent Director
- DYDavid York NortonIndependent Director
- RDRobert Dwyer McQuadeIndependent Non Executive Director
- Company NameCollegium Pharmaceutical, Inc.Stock CodeCOLLPositionIndependent ChairmanColleagues
- VKVikram KarnaniCEO, President & Director
- CTColleen TupperExecutive VP & CFO
- DDDavid DieterExecutive VP, General Counsel & Corporate Secretary
- TBThomas B. SmithExecutive VP & Chief Medical Officer
- IKIan KarpHead of Investor Relations
- GGGaren G. BohlinIndependent Director
- RJRita J. Balice-GordonIndependent Director
- NSNancy S. LurkerIndependent Director
